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Abstract
The omega (ome) gene product is a modifier of larval cuticle protein 5 and its alleles (and duplicates) in the
third instar of Drosophila melanogaster . Using deletion mapping the locus mapped to 70F-71A on the left
arm of chromosome 3. A homozygote null mutant (ome 1) shows a pleiotropic phenotype that affected the
size, developmental time of the flies, and the fertility (or perhaps the behavior) of homozygous mutant
males. The omega gene was verified as producing a dipeptidyl peptidase IV (DPPIV) by genetic analysis,
substrate specificity and pH optimum. The identity of the gene was confirmed as CG32145 (cytology 70F4)
in the Celera Database (Berkeley Drosophila Genome Project), which is consistent with its deletion map
position. The genomic structure of the gene is described and the decrease in DPPIV activity in the mutant
ome1 is shown to be due to the gene CG32145 (omega). The D. melanogaster omega DPPIV enzyme was
partially purified and characterized. The exons of the ome1 mutant were sequenced and a base substitution
mutation in exon 4 was identified that would yield a truncated protein caused by a stop codon. A
preliminary study of the compartmentalization of the omega DPPIV enzyme in several organs is also
reported.
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Introduction
Dipeptidyl peptidase IV (DPPIV, EC3.4.14.5) is a
multifunctional enzyme that is important in the
processing of numerous oligopeptides in many
organisms from bacteria to mammals. It belongs to
the prolyl oligopeptidase/S9 enzyme family
characterized by a Ser-Asp-His catalytic triad in the
C- terminal region. In humans and most mammals,
the prolyl oligopeptidase gene family consists of at
least: prolyl endopeptidase (PEP), acylaminoacyl
peptidase (ACPH), dipeptidyl peptidase IV (DPPIV)
and three proteins that have close sequence
homology to DPPIV (fibroblast activation protein
(FAP), DPPX and DPP10) and two peptidases
called DPP8 and DPP9 that have lower sequence
homology with DPPIV. The enzymes in this family
share highly conserved structural features and
moderately conserved amino acid sequence
homology (Chen et al., 2003). The DPPIV enzyme
and its close relatives are more highly conserved in
the C-terminal (an α/β - hydrolase domain) than in
the N-terminal region where the proteins form a
seven-bladed propeller region (Abbott et al., 2000
and included references). The N-terminal region
has one important 7 amino acid conserved
sequence in most of the family members
(DW(V/L)YEEE) and the first two glutamic acid
residues in this sequence have been shown to be
necessary for enzyme activity (Abbott et al., 1999).
DPPIV is a highly specific dipeptidyl
aminopeptidase that is characterized by the release
of an N-terminal dipeptide, Xaa-Yaa-|-Zaa-, from a
polypeptide, preferentially when Yaa is proline,
provided Zaa is neither proline nor hydroxyproline
(Prosite; BRENDA). The reactivity of the enzyme is
related to the amino acid in the penultimate
position that can be, after proline and alanine, the
following amino acids, with reactivity in this order:
pro>ala>>>ser>gly>val (and sometimes thr and
leu). In addition, the structure of the substrate’s
length and/or amino acid sequence immediately
surrounding the scissile bond and in the C terminal
region can also affect reactivity and/or specificity
(Boonacker, et al., 2003; Kühn–wache et al., 2003;
Mentlein, 1999; Ludwig et al., 2002; Gault et al.,
2003, De Meester et al., 2003).
In many organisms DPPIV is involved not only in
the proteolytic cleavage of dipeptides from the
NH2-terminus of a variety of biologically active
peptides, but also in activation of signal
transduction and cell matrix adherence processes.
In humans DPPIV (also known as CD26) functions
to process (primarily to inactivate) several peptides,
many of which are implicated in regulation of
immune, inflammatory, nervous and endocrine
functions (Abbott et al., 1999; Thoma et al., 2003).
No obvious phenotype is associated with this
enzyme in humans other than the apparent
involvement in glucose regulation and changes in
its expression in association with various disease
conditions (Boonacker, et al., 2003; OMIM).
Fischer rats lacking a functional DPPIV gene have
no visible phenotype, show no change in growth
rate and only minor physiological effects relating to
glucose tolerance (Boonacker, et al., 2003). The
enzyme seems to be a ubiquitous housekeeping
enzyme, but one whose synthesis is regulated in
some tissues (Boonacker, et al., 2003)
In insects, the enzyme activity was recognized in D.
melanogaster when transgenic flies with the
flounder antifreeze protein gene were found to
process the antifreeze protein by removal of an XP
dipeptide in the hemolymph. (Peters et al., 1993)
The enzyme has been reported in the blowfly,
Calliphora vicina , where a DPPIV activity was
isolated and shown to cleave the ecdysiostatic
peptide trypsin-modulating oostatic factor of
Neobellieria (Sarcophaga) bullata and in the brain
and intestine of the cockroach, where it is thought
to be involved in the inactivation of several
tachykinin related peptides (Martensen et al., 1998;
Nässel et al., 2000). In the cockroach high activity
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Lane 1: The cuticle proteins of third instar larvae from the wildtype stock (oreR) crossed into an ome1 background, Lane
2: wildtype, Lane 3: ome1/ome1 homozygote stock. The wildtype bands are numbered in white. The arrows indicate the
modified protein bands 5 and 6. Protein 6 is variant in the homozygote mutant (see Chihara and Kimbrell, 1986).
was obtained from the membrane fraction of the
intestine and some 10 fold less was found in brain
membranes. Both tissues also showed a smaller
amount of soluble activity (Nässel et al., 2000).
Suggested substrates for insect DPPIV include the
antibacterial cecropins, which are shown to be
activated by an aminopeptidase activity from
Hyalophora cecropia hemolymph (Boman et al.,
1989).
Five genes in FlyBase are expected to code for
DPPIV-like proteins in Drosophila melanogaster ,
CG11034, CG11319, CG32145 (omega), CG9059 and
CG3744 (Flybase). The mutant designated omega1
(ome1) was recovered in a screen for cuticle protein
variants and identified as a recessive modifier of
LCP5 (the larval cuticle protein 5) and its alleles,
shifting their migration pattern in native gel PAGE
(Fig. 1) (Chihara et al., 1986).
In this paper we confirm that the wildtype gene
omega is coded for by CG32145 and is a DPPIV
with specificity similar to, but not identical with,
human DPPIV. We clarify the action of the omega
DPPIV enzyme on the third instar cuticle proteins
LCP5 and LCP6, a protein related to LCP5 and most
probably a variant of a duplicated LCP5 (Charles et
al., 1998). We present data showing that omega
DPPIV has specificity that distinguishes it from
other DPPIV enzymes in the fly. Data on the
distribution of the enzyme in several organs, and
partial characterization of a partially purified
epithelial membrane fraction preparation of the
enzyme are also provided. This work further
confirms the nature of the ome1 mutant as deficient
in a DPPIV enzyme.
Materials and Methods
Fly stocks
ome1 and Lcp10rho are ethylmethane sulfonate
induced mutants previously described by Chihara
and Kimbrell (1986). The wildtype strain is an
Oregon R stock.
Fertility analysis
Five virgin females were placed in a vial with a
single male for five days at which point the females
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discarded. The offspring in all six vials (the original
vial and the five individual vials) were scored for
eleven days following the emergence of the first
adult fly. Ten replicates of each cross were
performed as listed.
female +/+ x +/+ male female ome1/ome1 x ome1/ome1 male
female +/+ x ome1/ome1 male female ome1/ome1 x +/+ male
female ome1/+ x ome1/ome1 male female ome1/+ x +/+ male
Modification of Oregon R “wildtype” LCP6
in the ome1 background
Virgin ome1 female flies were crossed to wildtype
males. The offspring males were backcrossed to
virgin ome1 female flies. Integument (cuticle) was
dissected from the back-cross third instar larvae
and run on non-denaturing gels as described in
Chihara and Kimbrell (1986). The larval proteins
were examined for heterozygous cuticle protein
variants in the homozygous ome1 background
similar to those seen in Fig. 1.
Deficiency mapping
ome1 virgin females were mated to deficiency stocks
to determine the cytological location of omega. A
minimum of 8 F1 larval cuticles were hand
dissected to reduce the probability of missing the
homozygote ome1 in any cross to less than 0.4%.
Cuticle proteins were extracted and run on gels as
described by Chihara and Kimbrell (1986).
Protein micro-sequencing
Third instar larval cuticles were prepared in
batches of 50 cuticles from wildtype, ome1 and
Lcp10rho and the proteins run on gels for analysis
as described by Charles et al. (1998).
Collections for developmental studies
To obtain eggs, stocks of young flies (2–3 days old)
were transferred to empty bottles that were then
inverted onto apple juice agar plates (Ashburner,
1989) that had been coated with yeast paste at 25°
C. A 2–hour pre–lay was followed by two hours of
egg laying for collection. Eggs were transferred to
vials of standard food in groups of 50. Triplicates of
400 eggs were counted in each experiment. For the
pupal stage, white prepupae were transferred to
new vials and the time recorded to within one hour
of pupariation. Flies were counted as they emerged
in 2–hour increments.
Preparation of larval enzyme extracts
Late third instar larvae were placed on a glass plate
(covered with aluminum foil and in snug contact
with an ice platform) and rolled with a pipet (used
like a rolling pin), or a solid brass metal cylinder
(~2 in. in diameter, weighing about 1 lb, and
wrapped in aluminum foil), depending on the
number of larvae, to extrude their insides. The
carcasses were then washed with cold Ringer’s
solution and homogenized in Buffer 1, [0.5mM
Phenylthiourea 0.38M Sucrose 0.1M Tris–HCl
pH7.5] in the proportion of 10 ml buffer/250 larval
carcasses. The homogenate was centrifuged and
washed in Buffer 1. The wash was added to the first
extract and called the “cytosol” fraction. The pellet
was re–extracted with the Triton–X containing
Buffer 2 [same as Buffer 1 with 1% Triton–X] using
500 µl/250 larvae in the same way as above, and
this extract was labeled the membrane fraction.
Enzyme assays
Chromogenic substrates and inhibitors were
purchased from Bachem (www.bachem.com). The
ingredients for buffers were purchased from Sigma
(www.sigmaaldrich.com). Human DPPIV was a
generous gift from Dr. Hans–Ulrich Demuth (of
ProbioDrug), or purchased from Sigma. The
standard end point assay was modified from
Mentlein (1989). Stock solutions of Gly-Pro-4-para
nitroaniline and Gly-Pro-β nalphthylamide, or
other chromogenic peptidase substrates, were
made in dimethylsulfoxide at a concentration of
100 mM or 200 mM. For nitroanilide substrates,
80 µl membrane fraction (or 500µl cytosol) was
incubated at pH 7.5 or 8 (0.1M Tris–HCl buffer) at
37° C for 15min. The final substrate concentration
was 0.5 mM. The reaction was terminated by the
addition of 10 µl 1M ZnCl2, and the samples
centrifuged for 2 min, at 14,000 x g in a micro
centrifuge. For –naphthylamide substrates the
method of Mentlein and Struckhof (1989) was used
with the following modifications: 50 µl of 5 mM
substrate solution (diluted in 0.1M Tris–Hcl, pH
7.5 or 8.0, from the stock solution) was mixed with
400 µl or 200 µl 0.1M Tris–HCl, and then
incubated with 50 µl membrane fraction enzyme
extract, or 250 µl “cytosol”, for 30 min at 37° C. The
kinetics assay for DPPIV hydrolysis was monitored
by a Hewlett–Packard (www.hp.com) diode array
spectrophotometer using Hewlett–Packard
Chemstation software in the kinetics mode. The
reaction was measured for 3 min at room
temperature. An initial rate was obtained with units
of AU/min/µg protein.
pH optimum
The pH optimum was determined using the
standard end–point assay (Martensen et al., 1998)
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bis-Tris, and HEPES, the mixture was adjusted to
the desired pH (pH range 5.5 to 10). The substrate
was Gly–Pro–βNA.
Inhibitors
For phenylmethanesulfonyl fluoride and ZnCl2
inhibition of the crude extract the enzyme
preparation was incubated with inhibitor for 2
hours before being added to substrate solution. The
enzyme reaction was then measured by the kinetics
assay as described above for 3 min. For inhibition
using the partially purified membrane fraction, the
enzyme–inhibitor samples were assayed with the
standard end–point assay. PMSF and bacitracin
were dissolved in DMSO, ZnCl2 in 1mM Tris buffer,
bestatin and diprotin A in methanol. Inhibitors
were added to enzyme extracts (at a final inhibitor
concentration of 0.1mM or 1mM) and
pre-incubated for 15 minutes at 37° C. All reactions
were controlled against Tris buffer or added DMSO.
Partial purification of DPPIV using DEAE
columns
Each crude enzyme preparation (7ml for membrane
fraction – equivalent to approximately 3500 larvae
– and 120 ml for the cytosol fraction – about 6000
larval equivalents) was applied to a column (3cm x
23.5cm) of DEAE–Sepharose fast flow (Amersham,
www5.amershambiosciences.com) equilibrated
with 0.1M NaCl/20 mM triethanolamine buffer, pH
8.5. The column was eluted with a linear gradient of
0.1–0.5 M NaCl/20 mM triethanolamine buffer
(500 ml total elution volume), and fractions were
collected (8–9 ml/fraction). For the purification of
the membrane fraction, 2% Triton X–100 was also
present in the column eluent. Every third tube was
assayed for enzyme activity. Active fractions were
combined and concentrated by ultrafiltration using
Jumbosept centrifugal concentrators (30,000 kD
Molecular weight cutoff, Pall Gelman,
www.pall.com) for 1 hour at 4° C at 3,000 g. Final
concentrate volume was 4–5 ml. The column was
washed with 200 ml of 1.0 M NaCl/20 mM
triethanolamine buffer, then 500 ml 0.1M NaCl/20
mM triethanolamine buffer between elutions. For
further purification and molecular mass
determination either crude extract or the
concentrate from the DEAE column was applied
onto a Superdex S–200 gel filtration column (2 cm
x 69 cm). 1.0 ml of extract was loaded and the
column was eluted with 200 ml of 0.1M NaCl/20
mM triethanolamine buffer (pH 8.5). 2.0 ml
fractions were collected and every third tube was
tested for dipeptidyl peptidase activity. The active
fractions were pooled and used for characterization.
The column was washed with 500 ml of the same
buffer between elutions.
HPLC test for specificity of enzymes
High pressure liquid chromatograpy (HPLC) was
performed using an Alltech (www.alltechweb.com)
Alltima C18 column (150 mm, 4.6mm, 5mm pore
size), with an elution gradient of 10-50%
acetonitrile/0.1% trifluoroacetic acid over 15
minutes, then 50–10% over 5 min. Eluent was
detected at 216 nm. The solvents used were 99.8%
acetonitrile/0.1% trifluoroacetic acid and 0.1%
trifluoroacetic acid in MiliQ water (the acetonitrile
and trifluoroacetic acid were from J.T. Baker,
www.jtbaker.com). 20mM triethanolamine buffer
was filtered through a 0.2 micron tuffrin filter
(Gelman Acrodisc) and used for all solutions and
dilutions of enzymes and substrates. Human
DPPIV was used as a control and for qualitative
comparison for all enzyme and substrate reactions.
The human DPPIV was stored and used as a
1–10,000 dilution (0.005µg/ml, from ProbioDrug
[www.probiodrug.de] or Sigma) in a phosphate
buffer. Extracts for processing of the trypsin
modulating oostatic factor (Asn–Pro–Thr–Asn–
Leu–His – MW696), substance P (Arg–Pro–Lys–
Pro–Gln–Gln–Phe–Phe–Gly–Leu–Met –
MW1349), and bradykinin (Arg–Pro–Pro–Gly–
Phe–Ser–Pro–Phe–Arg – MW1060) were tested.
The peptides were stored as stock solutions at 1 mM
concentration (in 20 mM triethanolamine buffer).
Final reaction concentrations were 100 µM
substrate with 2% (by volume) partially purified
membrane fraction in a reaction volume of 100 µl
for the trypsin modulating oostatic factor and
bradykinin, and 100 µM substance P with 10% (by
volume) membrane fraction in a reaction volume of
100 µl. Substrates were incubated with enzyme in
20 mM triethanolamine buffer for 90 minutes at
37° C. The reaction was then stopped by heat
denaturing the mixture at 90° C for 15 minutes.
Human DPPIV trials used 10 µU or 50 µU human
enzyme with 100 µM substrate in 100 µl reaction
volume. Controls were heat denatured at 90° C for
15 min prior to incubation. 20 µl of product was
loaded for HPLC. Prior to loading samples were
filtered through a 0.2 micron cellulose acetate
syringe filter that had been pre-rinsed in MiliQ
water and 20mM triethanolamine buffer.
Organ preparations
All organs were dissected in insect Ringer's
solution, transferred and stored frozen in Buffer 1
at –70° C until pooled and processed. Organs were
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Micro Waring blender for 90 seconds on high or by
a pellet pestle that fit in a 1.5 ml Eppendorf tube
depending on the size of the preparation. An
aliquot was reserved for protein assay and the
remaining homogenate was transferred to Oakridge
tubes and centrifuged for 3 hrs at 4° C, 20,000 g or
for 1 hour at 49,000 g at 4° C. The supernatant was
collected (labeled cytosol fraction) and stored at
–70 °C. The pellet was washed with Buffer 1 and
centrifuged at 20,000 g at 4° C for 5 minutes. The
supernatant was discarded and the pellet was
extracted with Buffer 2 by homogenizing in an ice
cold blender or tube and pestle for 2 minutes. The
homogenate was centrifuged at 49,000 g at 4° C for
30 minutes. The supernatant was collected (labeled
membrane fraction) and stored at –70° C, while the
pellet was discarded. Crude homogenate, cytosol
fraction, and membrane fraction were then assayed
for protein content and DPPIV activity.
2–3 day old males were dissected for testes and
accessory glands combined. Testes were quick
frozen in liquid nitrogen. For assay they were
defrosted and pooled to give a concentration of 1
testes/µl Buffer 1. Late third instar brains (lobes
and ventral ganglion) were dissected as above and
homogenized at a concentration of 1 brain/µl
(wildtype) and 1.6 brains/µl (ome1).
The adult brains were prepared from combined
males and females. Adults were placed on ice to
immobilize them and heads were removed in 1X
Ringer solution under the light microscope. The
heads were immediately placed in a 1.5ml
Eppendorf tube filled with liquid nitrogen with the
tube immersed in liquid nitrogen. At the end of
each dissection session the Eppendorf tube was
taken out of the pool of liquid nitrogen, allowing
the liquid nitrogen inside the tube to evaporate.
Immediately after all the liquid nitrogen had
dispersed, 200 µl ice cold Buffer 1 was introduced
into the tube and the heads were stored at –70° C.
Brains were homogenized at a concentration of 1
brain/µl Buffer 1. For homogenization, heads were
suspended in liquid nitrogen in a cold mortar and
pestle and ground into a powder that was then
transferred into a cold 1.5 ml Eppendorf tube.
Using a pestle for the Eppendorf tube, the samples
were further homogenized, brought to a volume of
800µl/100 heads with Buffer 1 and spun in an
ultracentrifuge at 20,000 x g for 4 hrs to recover
the cytosol fraction. The remaining pellet was
treated as above.
Ovaries were collected from aged virgin or
inseminated females. Ovaries (both lobed
structures including the oviduct and uterus
recognized as one unit) were isolated as above and
pooled, at a concentration of 1 ovary/5 µl Buffer 1,
and 3 ovaries/µl of Buffer 2 for the membrane
fraction. Each sample was processed in the same
manner as for testes, except the lipid layer was
removed and assayed separately.
Cloning of genomic wildtype DNA
Exons 3–10 were cloned from a P1 clone (DS00646
– obtained from the Berkeley Drosophila Genome
Project) digested with HindIII. Using a DIG labeled
probe of the degenerate probe 1 (Table 1) and EST
LD21715, positive colonies were isolated and the
DNA recovered and cloned using standard
procedures into pBluescript® II KS + (Stratagene,
www.probiodrug.de). Standard procedures using
the various probes as indicated were used to
identify and confirm the genomic DNA in all
cloning work (Table 1). Clones of exon 1 and 2 were
made after the Berkeley Drosophila Genome
Project published the D. melanogaster genome
sequence that made it possible to identify the gene
sequence in the database. Thus we used the
published sequence to generate primers for
isolation of the DNA by PCR from BAC 16F22
(obtained from Berkeley Drosophila Genome
Project). Primers were: Exon 1: Forward –
ATGTCTCGGGAAATGCCACC, Reverse –
CCATCCAAACTGACTTTAGG. Exon 2: Forward –
GCCGAACTGGAAACTGAATG Reverse –
GGGGAAACAATCTTTTTTTTGGGG. A standard
PCR procedure was used with an annealing
temperature of 53.2° C. The PCR products were
verified with DIG labeled probes for exons 1 & 2
respectively (Table 1) and then ligated into
Bluescript SK+ as above. The extent of the cloned
inserts was determined by sequencing (Seqwright).
Probes
The oligonucleotide probe for DWV(I)YEEE
(degenerate) was purchased from Genemed
Synthesis (www.genemedsyn.com). Other
oligonucleotide probes were obtained from Operon
technologies, Inc (www.operon.com). Probe
sequences were determined by reverse translation
of consensus protein sequences or afterwards
directly chosen from the Celera candidate genomic
DNA sequence (see Table 1). The oligo probes were
3' end labeled with the Digoxigenin Oligonucleotide
Tailing Kit (Boehringer Mannheim,
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# Protein seq. (DNA Source) Probe Sequence (5’-3’) Tm°C
1 DWV(I)YEEE probe (degenerate) 5’GAYTGGGTN(ATH)TAYGARGARGAR3’ 54
2 DWVYEEE probe (Drosophila AC017322) 5’GATTGGGTGTACGAGGAAGAG3’ 62.6
3 DDNVHYQ probe (Drosophila AC017322) 5’GATGATAATGTGCACTACCAGCAG3’ 62.9
4 3’ AC Probe (extreme 3’ end of AC017322) 5’CAGCTGCTACTAGAGAAGTGAG3’ 62.7
5 5’ UTR exon 2 probe (AC017322-5’end of exon 2) 5’CTGCAAAGTTAAGCGCGGGAA3’ 62.6
6 5’ UTR exon 1 probe (AC017215-5’end of exon 1) 5’CGGTTCGGTTTCGGTTACGGT3’ 64.5
www.roche.com), following the manufacturer’s
instructions. The full length EST LD 21715 was
obtained from the Berkeley Drosophila Genome
Project.
Genomic DNA preparation
Genomic DNA was extracted from the wildtype
strain and the ome1 mutant of D. melanogaster
according to protocol #48 in Ashburner (1989),
then digested by BamH I. Control mouse genomic
DNA was kindly provided by Xiaodong Shen
(UCSF, USA).
Sequencing of omega1 genomic DNA
ome1 DNA was prepared from whole flies and sent
to Laragen Inc. for PCR sequencing. Primers were
designed using the Gadfly sequence. Sequencing
was done twice on both strands and the sequence
compared with the wildtype sequence in Gadfly.
Differences from wildtype that occurred only in
both sequenced strands were considered valid.
Results and Discussion
The mutant phenotype
None of the co-dominant cuticle protein variants
identified from the original mutant screen (Chihara
et al., 1986) had any detrimental or visible
phenotype, whereas the recessive ome1 mutant
stock that also had a modified larval cuticle protein
(Fig. 1), seemed somewhat small and
developmentally “slow”. To confirm this
observation, the size and development of the ome1
stock was measured. ome1 showed no difference in
the wet weight of eggs, third instar larvae, or pupae,
however the ome1 adults (females and males) were
smaller by about 15–20% (Table 2). The
homozygous ome1 flies showed a delay in
developmental time of approximately one day over
the life cycle (Fig. 2), and no decrease in
developmental time during the pupal period. There
also was no difference in the percent of flies that
emerged when timed from the white prepupae (Fig.
3). It was concluded that the developmental delay
was in the larval period. This amounted to about a
20% delay (1 day out of 5) across the larval stages.
The ome1 homozygote males show a decrease of
about 40% both in the ability to fertilize females
(Fig. 4 ) and in the percentage of progeny flies per
female among successfully fertilized females (Fig.
5). Two tailed Student's t–tests were significant and
gave P value levels between 10–3 and 10–6.
Table 2. Percent wet weight - ome1/wild type. 400 animals at
each stage were weighed in groups of 100. The eggs, pupae
and larvae were washed and blotted dry.
%weight
Stage ome1/Wild type
egg 98
third instar larva 101
pupa 97
Adult female 84
Adult male 79
Cause of the shift in the mobility of LCP 5
and 6 in the ome1 mutant
In order to elucidate the mechanism of
modification of protein LCP 5 in the third instar
larval cuticle protein the ome1 mutant was
backcrossed the into a wildtype stock (mms) to
check the wildtype proteins directly in an ome1
background (Chihara et al., 1986) (Fig. 1).
Recombinants showed that both protein 5 and 6
were affected by the mutation. The N–terminal
ends of the mature proteins in the wildtype and
ome1 homozygote recombinants were sequenced
(Fig. 6). This sequence makes it clear that the shift
seen in the ome1 larval cuticle protein 5, and its
alleles and related duplicates (Charles et al., 1998),
can be explained by the lack of a DPPIV– like
processing of the N– terminal dipeptide
arginine-proline after the signal peptide is cleaved.
The Lcp10rho protein is produced by a
co–dominant ethyl methanesulfonate–induced
mutation and is not shifted in the ome1
background, i.e. is not cleaved by the enzyme. It is
clearly related to LCP5 by N–terminal sequencing
(Fig. 6), but it carries a serine residue in the
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Figure 3. The time of pupation measured from the formation of the white prepupa.
Figure 4. Percent fertilized females. For each cross, single males were introduced to a vial containing five females on
day one. On day five the male was discarded and the females were separated into individual vials. Those females that
produced offspring post day five were considered fertilized. In all cases the ome1 males were less successful at fertilizing
females. 'n' is the number of females in the sample. 'n < 50' indicates that some females died/escaped prior to
determining whether or not they had been successfully fertilized.
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males produced fewer living progeny/female. Note the apparent “hybrid vigor” illustrated in the heterozygote female
crosses. In this case as well, however, the ome1 males produced fewer progeny per female than the wildtype males. With
ome1 homozygote females a two tailed student's t test gave: P = 7.7x10-5, with wildtype females: P = 2.3 x 10-6,
heterozygote females: P = 9.9 x 10-3, where P is the probability that the samples are taken from the same population and
therefore have equal means. Number of females is the same as in Fig. 4 (../ref/figure4.html) .
Figure 6. Micro sequencing data of the N terminal residues of mature third instar Drosophila melanogaster cuticle
proteins. Note the extra N-terminal residues included in ome1 and Lcp10rho mutant proteins. Wild-type stocks are:
mms-multiple marked stock, and CS - Canton S (Chihara et al., 1986 (../#chiharaEA86) ). The sequenced N-terminal ends
of Lcp5 and Lcp6 are a 100% match with virtual sequence of cp65Agb1/2 from the 65A5-6 locus (Charles et al., 1997
(../#charlesEA97) ). Lower case amino acids indicate the putative signal peptide cleavage site from the genomic DNA
virtual translation.
penultimate position that must make it refractive to
ome1 DPPIV processing. Although a few DPPIV
enzymes are known to cleave after a penultimate
serine residue, most do not or do so with much
lower rates (Mentlein, 1999; Lambeir et al., 2001).
In any event, the omega wildtype enzyme does not
process this protein before it is exported to the
cuticle.
The omega gene maps to 70F–71A on
chromosome 3L by deletion
Prior to the publication of the Drosophila genomic
sequence a deletion map of the ome1 mutant was
constructed. A series of crosses with deficiency
chromosomes placed this DPPIV gene in 70F–71A
(Fig. 7). This is consistent with the hybridization
map position determined by the Berkeley
Drosophila Genome Project cytology for the EST
LD 21715 and for the gene CG32145 (originally
designated CG9370), thus confirming the identity
of the omega enzyme activity with CG32145, the
omega locus.
Gene structure and protein comparisons
A comparison of genomic sequence, our sequence
and the full length EST LD21715 (Berkeley
Drosophila Genome Project) was used to derive the
intron-exon structure of the gene. Analysis of the
sequence both from our studies and from the
Berkeley Drosophila Genome Project database
yields several interesting comparisons between this
Drosophila DPPIV (Fig. 8) and human DPPIV gene
structure.
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Figure 8. Exon structure of omega. Circles on ome+ cDNA indicate active site positions as labeled. The squares
pinpoint the positions of differences in the ome1 cDNA as ascertained from genomic sequencing.
The Drosophila gene omega includes a very large
intron in the untranslated 5' end of the RNA (all of
exon 1) whereas the first very large intron is
between exons 2 and 3 of the human gene (Abbott
et al., 1994). The original isolation of the omega
DNA was accomplished by comparing alignments
of over 12 eukaryotic DPPIV enzymes and
recognizing the consensus sequence DWVYEEE.
This highly conserved sequence, found in most, if
not all, of the DPPIV family of proteases, is the
conserved 7 amino acid sequence of the propeller
region (DW(V/L)YEEE), (Abbott et al., 1999) that is
common to S9b proteases (Fig. 9b). It is split
between exons 8 and 9 in the human but is found in
the single exon 4 in omega. Two glutamine residues
(glu205 & glu206 human and glu227 & glu228 in
omega) are extremely highly conserved (Abbott et
al., 1999; and this report Fig. 9a) and are required
for enzyme activity in human DPPIV (Abbott et al.,
1999). Each of the amino acid residues of the
Ser–Asp–His catalytic active site reside in a
separate exon in both species. In omega the
position of the conserved serine recognition
sequence GWSYGG is in exon 8 in contrast to the
human and mouse DNA where it is split between
two exons (21 and 22) (Abbott et al., 1994; 1995). It
has been suggested that the ancestral gene for the
DPPIV family in humans is either DPP8 or DPP9 in
that they have the smallest gene size and the fewest
exons (Abbott et al., 2000; Chen et al., 2003). The
serine recognition site in these two genes (DPP8 &
DPP9) is contained within a single exon, as it is in
omega and the other Drosophila putative DPPIV
proteins (Flybase). A phylogenetic tree (Fig. 9c) is
consistent with the omega protein being related to
the ancestral DPPIVs, with gene CG3744 being
more closely related to DPP8 & DPP9, and genes
CG11319 and CG9059 more distantly related and
appearing as outgroups.
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analysis). The numbers in parentheses indicate distance between the end of one and the beginning of the next sequence.
The highly conserved residues are in red. The catalytic triad is shown in underlined red bold, the conserved glutamic
acids are in green except for the QEE of the DPP8 related proteins (Q in blue). Note the substitution of Gly for Ser in
CG9059 (black G).The His residue reportedly necessary for dimer fomation is indicated under (dimer) in red bold (Chen
et al. 2004) and the residues that align with the required Tyr (Tyr547 in human DPPIV(Bjelke et al. 2004; Gorrell,
2005)) and the highly conserved Arg125 (Gorrell, 2005) are shown in square brackets.
Figure 9b. Broad structural comparison of several DPPIV proteins. DPPIV protein maps have been aligned to the
conserved sequence found within the N- terminal region (DW(V/L)YEEE) that contains the double glutamic acid
required for DPPIV activity (Abbott et al. 1999) This sequence is perfectly conserved except as indicated in Figure 9a.
The spacing between the omega conserved sites of the N- terminal conserved sequence and catalytic triad most
resembles the mammals, Aspergillus, and CG11034. The spacing of active sites for the other putative D. melanogaster
DPPIV genes does not match any of the others as well. The spacing for CG3744 most closely resembles DPP9.
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proteins from Uniprot (www.expasy.org/prot).
Thus, it would seem that the human gene
represents a splitting of most of the ancestral exons
into the 26 we see now, with exons varying in
length from 15 to 65 residues. We have compared
the 300 5' flanking bases of omega to those of the
human DPPIV gene and find 41% identity in
sequence. Like the human upstream region there is
no TATA box, and there is only one complete AP1
site. In D. melanogaster the AP1 is on the minus
strand.
The virtual protein sequences of the four additional
putative DPPIV genes in D. melanogaster were
compared to each other and to several other
DPPIV–like proteins, including human DPPIV and
the related proteins FAP, DPP8 and DPP9. The
pileup of conserved sequences (Fig. 9a) of several
known DPPIVs and DPPIV–like proteins, including
the D. melanogaster genes, shows the active site
consensus sequences and the relation between
these DPPIV–like proteins and the DPPIVs. A
simplified alignment of the proteins to display the
spacing between the main conserved sites, the
N–terminal S9b conserved sequence, and the
Ser–Asp–His catalytic triad, shows considerable
agreement between the mammalian and D.
melanogaster DPPIVs. (Fig. 9b) The distance
between the 7 base conserved sequence
(DWVYEEE) and the beginning of the catalytic
triad is very similar for the mammalian proteins
and for D. melanogaster omega and CG11034 (Fig.
9a & Fig. 9b). The internal spacing for the
Ser–Asp–His triad is fairly well conserved across
the list, but the distance from the 7 base consensus
sequence, DWVYEEE, to the triad differs notably
for the D. melanogaster genes CG9059, CG11319
and CG3744 and for human DPP8 & 9. In human
DPPIV Tyr547 was shown to be required for activity
of the enzyme (Gorrell, 2005), and this residue is
perfectly conserved across these proteins except for
CG9059, which is also missing the highly conserved
Arg125 residue. Thoma et al. (2003) report that the
distance between the double Glu residues and the
catalytic serine is important in limiting cleavage to
dipeptides and the size and shape of the region
surrounding the P1 proline restricts the specificity
of the enzyme to proline (and a few other amino
acids in this position with lower activity). Note that
of the four other D. melanogaster proteins, only the
configuration for the CG11034 is overall similar in
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proteins. The other putative D. melanogaster
DPPIV proteins CG9059, CG3744 and CG11319
(Flybase, Abbott et al., 1999) are quite different,
either in the distance of the N terminal end to the
DWVYEEE consensus sequence or in the distance
from it to the serine recognition site. The alignment
for these proteins shows a similar consistency in
the sequences of the four active sites as well as the
spacing (Fig. 9b). Note that only the CG3744 gene
of the D. melanogaster putative DPPIV proteins
has the N– terminal (propeller) motif QEE seen in
the more closely related human proteins DPP8
(Uniprot Accession # Q6 V1x1) and Dpp9 (Uniprot
Accession # Q6UAL0) (Fig. 9a). Note that for the
proteins shown in Fig. 9a, all display the conserved
histidine (human His750 and omega His779)
residue reported by Chen et al, (2004) to be
required for human DPPIV dimer formation with
the exception of the Aspergillus enzyme and
CG3744. Presumably the Aspergillus enzyme
functions as a monomer. However, the DPP8 and
DPP9 proteins are also reported to function as
monomers (human DPPIV does not) indicating this
conserved histidine is not an adequate indicator of
dimerization for these proteins (Abbott et al.,
2000).
Pair–wise comparisons among the mammalian
proteins show amino acid similarity (including
identities and similarities) ranging from 80% to
93%, while the D. melanogaster omega –
mammalian DPPIV similarities ranged from 30 to
46%. Pair-wise comparisons of omega protein with
CG 11319 and omega with CG11034 show them to
be as similar to each other as they are to the
mammalian proteins (43% and 46% respectively),
and the similarity to CG9059 and CG3744 is much
less (19% & 17% respectively). CG3744 compared to
DPPIV 8 and 9 give similarities of 31 and 32%
respectively. It is certainly possible that these
differences relate to different substrate specificities.
CG9059 lacks the serine residue within the
consensus sequence of the serine recognition site,
the highly conserved tyrosine within the hydrolase
domain, and one of the conserved glutamic acids in
the propeller sequence, and so presumably is not
active as a DPPIV. At least one of the 3 additional
D. melanogaster gene products (CG3744, CG11319
and CG11034) must have DPPIV activity as we see
it as residual activity in the ome1 mutant. This will
be further discussed below.
Cloning of wildtype omega gene
The genomic exons of ome+ were cloned into three
separate vectors for further analysis. The exon 1
clone included about 1000 bases of upstream
sequence and the exon 2 clone about 180 bases of
intron 1 and about 85 bases of intron 2. Exons 3–10
were incorporated into one clone of about 5kb. All
were cloned in Bluescript SK+. These clones will be
provided to any researcher who might want them.
The ome1 mutation is a result of a nonsense
mutation in exon 4
All of the exons and 140 bases upstream of the
ome1 mutant allele were sequenced on both
strands. The entire DNA of the exons and upstream
region was wildtype with two clear exceptions. Two
base substitutions were found, one in exon 3 that
changed a valine to a leucine (GTT to CTT) and one
in exon 4 that converted a tryptophan codon to a
stop codon (TGG to TAG). (Fig. 8). We presume
this stop codon is the cause of loss of enzyme
activity. The ome1 exon sequences have been placed
in GenBank: Genbank accession numbers:
AY245164, AY245165, AY245166, AY245167,
AY245168, AY245169, AY245170, and AY245171
The omega enzyme is a fly DPPIV (EC
3.4.14.5)
DPPIV is a serine protease with specificity for
cleaving on the carboxy side of a penultimate
proline residue at the N terminal end of a protein
(or, with less activity, an alanine and, even slower,
when a ser, gly or val). The enzyme is most
frequently membrane bound, although there are
soluble forms reported (Perner et al., 1999; Durinx
et al., 2000). To test if the missing enzyme in ome1
homozygotes was DPPIV we made crude
homogenates of both wildtype and ome1 larval
“epithelia” (see Methods for carcass preparation),
since we assumed that this tissue would contain the
enzyme in order to process the secreted cuticle
protein. The wildtype extract had prolyl specific
dipeptidase activity on artificial substrates (see
below) to a much higher level than did the ome1
mutant extract.
DPPIV activity of both the membrane and soluble
fractions from D. melanogaster wildtype and ome1
third instar larval “epithelia” homogenates were
assayed with the chromogenic substrates
Gly–Pro–4–nitroanilide (Gly–Pro–pNA) or
Gly–Pro–β–naphthylamide (Gly–Pro–βNA).
Gly–Phe–pNA was used as a control to estimate the
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non–specific peptidase activity from the crude
extract homogenate. Using a kinetics assay, DPPIV
activity (per µg protein) in the wildtype crude
membrane fraction at pH 7.5 upon Gly–Pro–pNA is
3 times that of the ome1 membrane fraction; for
membrane fractions from both wildtype and ome1
homogenate there was no enzyme activity upon
Gly–Phe–pNA. This was the first indication that
the ome1 mutant contained a residual DPPIV
enzymatic activity (Fig. 10a). Cytosol fractions for
both the wildtype and ome1 from the homogenate
showed some activity upon both Gly–Pro–pNA and
Gly–Phe–pNA. The level of the enzyme activity
differed between the two substrates, but there was
no major difference between wildtype and ome1 for
both substrates (Fig. 10a).
On the natural substrate (Lcp5) we saw preferential
degradation of the ome1 Lcp5 protein, but
concurrent degradation of contaminating proteins
by proteases in the .png preparation made
quantification impossible. However, we did find
that the wildtype extract degraded the unprocessed
ome1 LCP5 more rapidly than the ome1 extract and
human DPPIV did not process it at all (data not
shown). This is suggestive of differing specificities
for the D. melanogaster and human homologs of
DPPIV as well as for the major and residual
activities of the D. melanogaster enzymes.
The molecular weight of LCP5 is as large as the
largest peptides reported for most human DPPIV
substrates; the molecular weight after the signal
peptide is removed is about 9.6kD for 86 amino
acids. Most substrates we found reported for
human DPPIV ranged between 66 and 77 amino
acids RANTES (P13501)–68 amino acids, 76 & 77
amino acids for the chemokines CCL2 (P13500)
and IP–10 (P02778) respectively, after the signal
peptides are cleaved (UniprotKB/Swissprot
entries). The only substrate we found larger than
this was CXCL9 (MIG) that has 103 amino acids
and is cleaved considerably slower than most of the
other substrates (De Meester et al., 2003).
Using the more sensitive end point assay,
Ala–Phe–Pro–pNA was tested with the wildtype
and ome1 membrane fractions and there was a large
difference between them. The wildtype membrane
fraction cleaved Ala–Phe–Pro–pNA, while the ome1
membrane fraction had no activity; the wildtype
cytosol fraction showed ~30% higher activity on
Ala–Phe–Pro–pNA than ome1 (see Fig. 10b). The
only identified D. melanogaster tripeptidyl
peptidase in the genomic database is TPPII and this
enzyme does not cleave substrates with the
Ala–Phe–Pro N–terminal sequence (Renn, 1998,
Brenda). To test if this result could be explained by
the cleavage of Alanine from the tripeptide followed
by DPPIV activity, Ala–pNA was tested. The
Ala–pNA was cleaved by membrane and cytosol
fractions of both the wildtype and ome1 without
significant difference between them (See Fig. 10c).
We interpret these data to mean that both
membrane fractions cleaved the Ala N terminal
amino acid from the Ala–Phe–Pro pNA, equally
well, and that the wildtype can, but the ome1
mutant can not, continue the degradation of the
remaining Phe–Pro–pNA substrate.
Furthermore, Gly–pNA and Pro–pNA were tested
with the wildtype and ome1 crude extract to clarify
that it was DPPIV in wildtype that cleaved the
Gly–Pro–pNA rather than that Gly was first cleaved
by one enzyme other than DPPIV, then Pro was
cleaved. Both membrane and cytosol fractions from
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Ala-phe-pro-pNA compared to Gly-pro-pNA.
Figure 10c. wt = wildtype, Ala-pNA, Pro-pNA and Gly-pNA, (average of three experiments) - using the end point
assay.
larval crude extract cleaved Gly–pNA, and there
was no difference between the wildtype and ome1.
However, cytosol fractions cleaved Gly–pNA to a
much lower degree, compared to the membrane
fractions (Fig. 10c). Both membrane and cytosol
fractions from wildtype and ome1 have little activity
upon Pro–pNA (Fig. 10c). The cytosol fractions of
both wildtype and ome1 showed some non–specific
activity for the Gly–Phe substrate as well as equal
and very low levels of activity on the Gly–Pro
substrate. This suggests that there is another
DPPIV like enzyme in the cytosol unrelated to the
omega gene (see later discussion). The crude
extract of the membrane fraction from epithelial
tissue of ome1 larvae showed a decrease of at least
66 to 80% in activity for either substrate
Gly–Pro–pNA or Gly–Pro–βNA (data not shown)
over the same membrane fraction prepared from
ome+ homozygotes. Given the lack of difference in
the activity of the cytosol fraction between wildtype
and mutant, we conclude that the missing omega
enzyme is primarily a membrane bound protein in
this tissue, which is consistent with its function of
processing the larval cuticle proteins, LCP5 &
6(lcp65A).
Partial purification of membrane fraction
activity:
Larval carcass enzyme preparations from the
cytosol fractions were purified about 20 fold by the
DEAE column, but the overall purification
decreased by approximately half after the gel
filtration elution. The wild–type membrane fraction
gave better partial purification, but the ome1
membrane activity was only purified about 13–fold
due to the low level of starting activity and decrease
in enzyme activity. The membrane fraction activity
obtained from the two columns (MFGF >90 fold
purification) was used for further characterization
(Table 3).
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Fraction, CF: Cytosol Fraction, CH: Crude Homogenate, GF: Sample run through the DEAE column then the Gel
Filtration Column, DEAE: Extracts run though DEAE column only, WT: Wild-type. Percent Yield was calculated by the
total activity at a given step/total activity of the crude extract. Fold purification was calculated as specific activity of a
purified sample/specific activity of the crude extract.
Enzyme Fraction Total Activity Total Protein (mg)
Specific Activity
(Abs/mg Protein) % Yield Fold Purification
WT CH 787.5 427.63 1.84 100.00
WT MF 296.4 86.33 3.43 37.64 1.86
WT MF DEAE 228.8 2.19 104.35 29.05 56.71
WT MF GF 86.6 0.5 171.51 11.00 93.21
WT CF 541.2 367.96 1.47 68.72 0.80
WT CF DEAE 74.2 3.95 18.8 9.42 10.22
WT CF GF 35.18 1.25 28.2 4.47 15.33
Ω CH 70.8 116.39 0.61
Ω MF 45.38 39.46 1.15 64.09 1.89
Ω MF DEAE 19.95 5.45 3.66 28.18 6.01
Ω MF GF 3.78 0.47 8.06 5.34 13.26
Ω CF 75 86.98 0.86 105.93 1.42
Ω CF DEAE 42.24 3.8 11.13 59.66 18.29
Ω CF GF 5.16 0.39 13.29 7.29 21.84
Table 4. Elution ratios and estimated molecular weights of the DPPIV preparations. Each value is an average of 3 trials
+/- (SE%). For the purposes of Molecular Weight determination, the elution volume used to determine the Elution to
Void Volume ratio (VE/VO) is the volume of the highest absolute enzyme activity.
Wild-type MF Wild-type CF Omega MF Omega CF
VE/VO 1.135 1.145 1.17 1.19
Molecular Weight (kDa) 256000 (4.7%) 233000 (3.8%) 212000 (7.6%) 193,600 (10.2%)
Figure 11a. Enzyme activity of partially purified Wildtype and ome1 membrane fractions eluted from the Gel Filtration
column. The insert shows the molecular mass of standards and fractions.
Molecular weight determination:
The partially purified enzyme activity of each of the
two membrane fractions (wildtype and ome1) is
shown in Figure 11a and the cytosol fractions are
shown in Fig. 11b. The four fractions eluted at
different molecular weights as shown in Fig. 11a &
Fig. 11b and Table 4. When compared to the
predicted MW of the omega wildtype gene product
(90,222 D) it appears that the enzyme functions as
a dimer, and most probably has been
post–translationally modified as well. These data
are consistent with those seen in mammalian
DPPIVs where the enzyme is highly glycosylated
and commonly functions as a dimer. Virtual
translations for the gene transcripts of CG9059 and
CG3744 give dimer molecular weights too large for
the mutant ome1 residual activity. CG11319 is too
large for the cytosolic residual activity. Since the
known DPPIVs that are similar to omega DPPIV
seem to be glycosylated dimers (Polgar, 2002),
these data are consistent with omega DPPIV and
CG11034 product being glycosylated proteins. The
data also support the idea that the residual activity
in the ome1 mutant is coded for by CG11034.
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Table 5. Comparison of molecular weights to predicted molecular weights for the five putative D. melanogaster
DPPIVs. %difference of virtual wt - estimated wt/estimated weight. Only omega and CG11034 fit the expected MW value
allowing for glycosylation.
Fraction
Apparent
Molecular
Weight(kDa) from
GF column
omega gene virtual
molecular weight:
monomer/ dimer
CG11034 virtual
molecular weight:
monomer/dimer
CG9095 virtual
molecular weight:
monomer/dimer
CG11319 virtual
molecular weight:
monomer/ dimer
CG3744 virtual
molecular weight:
monomer/ dimer
90,222.37/180,444 84,495/168,990 116,497/232,994 104,715/207,430 122,528/245,056
Dimer
difference/ome
Dimer
difference/ome
Dimer
difference/ome
Dimer
difference/ome
Dimer
difference/ome
Wild-type MF 256,000 -29.50% -34% -8.90% -18.99% -4.30%
Wild-type Cytosol 233,000 -22.50% -27% 0.00% -10.90% 5.10%
W MF 212,000 -14% -20.00% 9.90% -2.10% 15.60%
W Cytosol 193,000 -6.50% -13.40% 20.70% 7.40% 26.90%
Since most DPPIVs in vivo are glycosylated (Polgar,
2002), glycosylation is a likely explanation for the
differences between calculated and observed
molecular weights. In addition, when the D.
melanogaster enzyme was exposed to
endoglycosidases 2 and 3, the amount of DPPIV
activity present in both wildtype and omega
membrane fractions decreased by 85%, while when
exposed to another endoglycosidase
(endoglycosidase 1) in a similar assay, the activity
was unaffected (data not shown). A possible
explanation for this is that the enzymes are
glycosylated and the removal of certain sugar
groups (by endoglycosidase 2 and 3) disrupted the
DPPIV activity, although a recent study indicates
that glycosylation is not critical for activity of the
human enzyme (Aertgeerts et al., 2004). The amino
acid sequence of the human protein has 8 possible
glycosylation sites when analyzed by NetNGlyc 1.0
for human proteins. (Analysis from
http://www.cbs.dtu.dk/services/NetNGlyc)
Thus the apparent molecular weight of human
DPPIV is 110–120 kD for the monomer, and 264 kD
for the functional dimer (De Meester et al., 1992;
Polgar, 2002) while the calculated molecular
weight from this sequence is 88,278 D (~177 kD for
a homodimer).
(http://www.expasy.org/cgi-bin/niceprot.pl?P27487).
And
(http://mpr.nci.nih.gov/prow/guide/61856995_g.htm)
When plugged into the NetNGlyc 1.0 human
analysis program the omega DPPIV amino acid
sequence possessed 4 possible N–linked
glycosylation sites. If D. melanogaster proteins are
legitimately analyzed in this way, this could explain
the apparent molecular weight of 256 kD for a gene
product predicted to have a molecular weight of
180.4 kD as a dimer (Table 5). Mammalian DPPIVs
can have as much as 22.7% of their weight as sugar
moieties. (Brenda). In comparison to human
DPPIV, the increase of molecular weight of the
omega DPPIV from the predicted molecular weight
(from the amino acid sequence) to the estimated in
vivo molecular weight is comparable. (Table 5) The
data are consistent with the CG11034 gene coding
for the residual DPPIV and also functioning as a
dimer, with a dimeric weight of 168,990D (Table 5).
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Figure 12b. (b) pH curve for the partially purified cytosol fraction of wildtype (WT CF) and ome1 (ome1 CF) DPPIV.
The pH optimum
The pH optimum for the crude enzyme showed a
broad peak around pH 8.0 (data not shown). The
partially purified wildtype fraction shows two
distinct pH optima in the membrane fraction (Fig.
12a) and a broad peak in the cytosol (Fig. 12b) a
pattern consistent with more than one enzyme.
Both graphs indicate that we have at least two
different enzymes capable of cleaving the artificial
substrate used for assay. The ome1 mutant is clearly
missing the enzyme with the higher pH optimum in
both compartments. We thus assume that the pH
optimum for the wildtype omega gene product
(omega DPPIV) is approximately 8.5 in both the
membrane bound and soluble form.
Inhibitors
Two DPPIV inhibitors, PMSF, a general inhibitor of
serine proteases and ZnCl2, a known inhibitor of
mammalian DPPIV, were tested on D.
melanogaster third instar larval crude carcass
extract. Diprotin A, bacitracin and bestatin were
also tested on the partially purified extracts. 2mM
ZnCl2 completely eliminated the enzyme activity.
2.5 mM PMSF decreased the DPPIV activity by 78%
for membrane fraction. As with the pH there are
differences between the wildtype and mutant
sensitivities, again indicating that different
enzymes are functioning in the two strains (Table
6). The wildtype enzyme extract behaved more like
human enzyme in its response to the inhibitors
then either the ome1 mutant residual enzyme
activity or the blowfly and cockroach enzymes,
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+: sensitivity between 50-75%,++:sensitivity between 25-50%,+++: sensitivity 25% or less
A: From Nassel et. al 2000
B: From Martensen et al 1998
C: From De Meester et al, 1992 and Mentlein et al, 1986
D: Buckley et al, 2004
E: From O'Connor and O'Cuinn, 1986
Inhibitor BlowflyB CockroachA HumanC,D
& MammalianE WT MF WT CF ome1MF ome1CF
DPP IV
PMSF +++ - ++C +++ +++ ++ ++
Diprotin A - +++ +++C +++ +++ - -
ZnCl2 +++ - +++C +++ +++ + +
Bacitracin - N/A +++E - + - -
Bestatin - - +D - - - -
however it must be kept in mind that the wildtype
extract is a mixture of at least two DPPIVs.
Characterization of activity on known
substrates for DPPIV
In order to determine if the nature of the activity of
the partially purified enzyme preparation was
comparable to human DPPIV we tested the
partially purified MF on several substrates and
compared the degradation products with the
activity of Human DPPIV. Bradykinin is a
nonapeptide (Arg–Pro–Pro–Gly–Phe–Ser–Pro–
Phe–Arg) with a proline following the penultimate
proline. As such it should not be, and was not,
degraded either by human or Membrane Fraction
DPPIV (data not shown).
The trypsin modulating oostatic factor
(Asn–Pro–Thr–Asn–Leu–His) is a hexapeptide
found in the blowfly, Calliphora vicina , and is
believed to be a natural substrate for DPPIV in that
fly (Martensen et al., 1998). Both human DPPIV
and the partially purified membrane fraction were
able to cleave the Asn–Pro dipeptide from the N–
terminal end. (Fig. 13A–E). The trypsin modulating
oostatic factor control has a peak at 4.8 – 5
minutes. Once incubated in the presence of either
enzyme the peak shifts to 3.75 minutes, consistent
with a tetrapeptide. The additional dipeptide is
expected to run in the solvent front (dipeptide
controls not shown).
Substance P (Arg–Pro–Lys–Pro–Gln–Gln–Phe–
Phe–Gly–Leu–Met) was then tested to verify that
the membrane fraction enzyme was removing the
dipeptide as a unit. We compared the cleavage of
human and membrane fraction enzyme and the
same degradation products were observed from
both enzymes (Fig. 13F–H). The substance P
control exhibits a peak at 12 minutes. Digests show
three peaks: the substance P peak at 12 minutes,
and two new peaks at 5.8 and 7.2 minutes. The
appearance of two product peaks is consistent with
DPPIV activity. Both Substance P and the first
cleavage product, a 9 amino acid molecule
(Lys–Pro–Gln–Gln–Phe–Phe–Gly–Leu–Met),
have the N– terminal structure recognized by a
DPPIV type enzyme. If the activity present in the
larval extract were, for example, a DPPII, then one
would expect 4 unique substrate peaks for the
enzyme extract (Fig. 13F–H). Thus the D.
melanogaster enzyme activity is consistent with a
classic DPPIV dimeric enzyme with a slightly
alkaline pH optimum, and the ability to remove an
N– terminal X–proline dipeptide.
The substrate and inhibitor specificities, membrane
association, and pH optimum of the omega gene
protein are consistent with the characteristics of
DPPIV in other organisms. The conserved
sequences known to be characteristic of the DPPIV
enzymes are found in both omega and CG11034
protein sequences. The molecular weights and
evidence of dimerization in the omega enzyme
activity lead us to conclude that the omega gene
codes for a major D. melanogaster DPPIV and that
in the carcass of the larva the genes omega and
CG11034 are coding for the main enzymes. The data
indicate that there are other DPPIV–like enzymes
in the various D. melanogaster tissues. This is
consistent with the information in GadFly
indicating that there are four other possible
DPPIV–like enzymes. Given that cuticle protein 5 is
not modified at all by the ome1 mutant or its
extracts we suggest that the omega gene is the
primary enzyme with this activity and that the
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carcass adhering cells. den. = denatured by boiling for 10 min. The dipeptide products were not resolved (control
dipeptides ran with the solvent front). ? Control substrate; ? Cleaved product; ? between solvent front peaks. Both
membrane fraction and the human enzyme gave unexplained noise around the smaller peptide peaks.
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from carcass adhering cells. den. = denatured by boiling for 10 min. The dipeptide products were not resolved (control
dipeptides ran with the solvent front). ? Control substrate; ? Cleaved product; ? between solvent front peaks. Both
membrane fraction and the human enzyme gave unexplained noise around the smaller peptide peaks.
Table 7. Comparison of compartmentalization of DPPIV activities in various organs.
* averaged over 10 experiments.
** average of at least four experiments.
Cytosol % ome1/WT
Membrane Fraction %
ome1/WT
Compartment of major
omega activity
Major DPPIV gene
activity
*carcass (crude extract) 75 40 MF omega
**larval brain 50 84 cytosol ?
**adult brain 82 28 MF ?
**adult testes 7 55 cytosol omega
**adult ovaries (virgin) 37 6 MF omega
substrate specificities of the other enzyme(s) are
different.
Differential compartmentalization of the
DPPIV activity
Using whole animals, two microarray expression
studies have shown that the mRNA for omega is
expressed during embryogenesis at about 12 hours
of embryonic development (Flybase: Gene
Expression Data) and in larvae and pupae from 18
hours prior to pupariation through 12 hours post
pupariation. The peak of this activity was at
pupariation (White et al., 1999). We have looked at
the activity in membrane and cytosol from several
isolated organs of the late third instar larva and the
adult.
The distribution of the enzyme activity differs
between organs in both stages. In the larva the
brain (and ventral ganglion) and the carcass were
examined. The compartmentalization of the brain
activity is opposite that of the epithelium (carcass).
The main activity in the carcass is omega and is
primarily in the membrane fraction, whereas the
main activity of the brain is in the cytosol and is
split between the omega gene product and the
residual activity (Fig. 10A, Fig. 14 A–B and Table 7).
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least four preparations.
a: Membrane fraction comparison of total DPPIV activity/µg protein.
b: Cytosol fraction comparison of DPPIV activity/µg protein.
c: µg protein/organ for membrane fraction.
d: µg protein/organ for cytosol fraction.
Ovaries data are for aged virgins. Inseminated and virgin ovaries were assayed from 5-10 day old females. The data
presented here are for virgin ovaries, as these data were less variable than for ovaries from inseminated females. In
inseminated females the average activity for membrane fraction of ome1 was ~53% of wildtype and for the cytosol ~23%
of wildtype.
Adult brain, testes and ovary were tested in the
same way. Adult brains had relatively low overall
activity, with the major activity level in the cytosol
and the omega enzyme more important in the
membrane fraction. In the adult cockroach similar
compartmentalization was found between
membrane and soluble forms with major activity in
the membrane fraction. The cockroach also had
similarly low levels of activity in the adult brain
(Nässel et al., 2000). The adult testes had quite
high activity (per µg protein) and most of it was in
the cytosol. The membrane fraction activity was
split almost equally between the omega enzyme
and the residual activity. The adult ovaries,
however, partition in exactly the opposite way, with
high activity in the membrane fraction and
relatively little in the cytosol. In the ovaries the
main enzyme seems to be the omega product
(Table 7).
Three organs had high activity levels (larval brains,
adult ovaries and testes) for combined DPPIV
activity. In ovaries and testes the major portion of
the activity was omega DPPIV, while the larval
brain activity seems to be fairly equally split
between omega and the residual enzyme activity.
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than their wildtype counterparts with the possible
exception of the adult brains (heads) and ovaries
(Fig. 14 C–D). Although the larvae did not show a
difference in weight, the adults were slightly
smaller (Table 2).
The omega gene DPPIV is more important in the
cytosol of the adult brain, but the combined enzyme
activity here is relatively low. In addition, the larval
brain membrane fraction has a high enzyme
activity, but it does not seem to be the omega gene
product. It will be interesting to discover which of
the alternate DPPIV genes accounts for the
“residual” DPPIV activity in each of these organs, as
well as what connection loss of the enzyme has to
the observed phenotypes.
The D. melanogaster omega DPPIV seems to be a
ubiquitous enzyme, which is characteristic of
mammalian DPPIV, but does not seem to be a
“simple housekeeping enzyme”. There is clearly
differential compartmentalization of the omega
DPPIV activity into membrane bound and soluble,
as well as differential expression across the life
cycle and organs of the fly. The difference in activity
per unit protein between the wildtype and the
mutant in the testes cytosol and in the membrane
fraction of the ovary indicates that the enzyme has
an important role in these two tissue
compartments. Why the loss of omega DPPIV
seems to be associated with a decrease of male
fertility, but not with female fertility remains to be
seen.
The search for other natural substrates for the D.
melanogaster DPPIVs must include the immunity
proteins and proteins that could effect the fertility
of the males. Among the immunity proteins the
diptericin precursor has a signal sequence followed
by two amino acid pairs Y P M P thought to be
removed by a DPPIV activity. Defensin, drosocin,
and metchnikowin also have a signal sequence
followed by X – P that is also believed to be
removed by Dipeptidase activity during activation
(Data from PIR. A47103, M55432, Q24396). It
remains to be seen which DPPIV activity in the fly
processes these important proteins.
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